269 related articles for article (PubMed ID: 26016513)
21. Atherothrombosis and high-risk plaque: part I: evolving concepts.
Fuster V; Moreno PR; Fayad ZA; Corti R; Badimon JJ
J Am Coll Cardiol; 2005 Sep; 46(6):937-54. PubMed ID: 16168274
[TBL] [Abstract][Full Text] [Related]
22. Links between inflammation and thrombogenicity in atherosclerosis.
Viles-Gonzalez JF; Fuster V; Badimon JJ
Curr Mol Med; 2006 Aug; 6(5):489-99. PubMed ID: 16918370
[TBL] [Abstract][Full Text] [Related]
23. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
[TBL] [Abstract][Full Text] [Related]
24. Procoagulant microparticles: 'criminal partners' in atherothrombosis and deleterious cellular exchanges.
Morel O; Toti F; Bakouboula B; Grunebaum L; Freyssinet JM
Pathophysiol Haemost Thromb; 2006; 35(1-2):15-22. PubMed ID: 16855341
[TBL] [Abstract][Full Text] [Related]
25. Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis.
Cheng X; Qiu X; Liu Y; Yuan C; Yang X
Thromb Res; 2019 May; 177():110-116. PubMed ID: 30875490
[TBL] [Abstract][Full Text] [Related]
26. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets.
Stojkovic S; Thulin Å; Hell L; Thaler B; Rauscher S; Baumgartner J; Gröger M; Ay C; Demyanets S; Neumayer C; Huk I; Spittler A; Huber K; Wojta J; Siegbahn A; Åberg M
Thromb Haemost; 2017 Jun; 117(7):1379-1390. PubMed ID: 28492698
[TBL] [Abstract][Full Text] [Related]
27. [Pathology of AtheroThrombosIS (ATIS)].
Ueda M
Drugs; 2010 Nov; 70 Suppl 1():3-8. PubMed ID: 20977286
[TBL] [Abstract][Full Text] [Related]
28. Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation.
Meerarani P; Moreno PR; Cimmino G; Badimon JJ
Indian J Exp Biol; 2007 Jan; 45(1):103-10. PubMed ID: 17249334
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells.
Li S; Chen H; Ren J; Geng Q; Song J; Lee C; Cao C; Zhang J; Xu N
Atherosclerosis; 2014 Dec; 237(2):514-20. PubMed ID: 25463083
[TBL] [Abstract][Full Text] [Related]
30. [New insights into the etiopathogenesis of atherosclerosis and atherothrombosis].
Herman AG
Bull Mem Acad R Med Belg; 2006; 161(3-4):213-25; discussion 226-7. PubMed ID: 17172227
[TBL] [Abstract][Full Text] [Related]
31. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
32. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.
Stakos DA; Kambas K; Konstantinidis T; Mitroulis I; Apostolidou E; Arelaki S; Tsironidou V; Giatromanolaki A; Skendros P; Konstantinides S; Ritis K
Eur Heart J; 2015 Jun; 36(22):1405-14. PubMed ID: 25660055
[TBL] [Abstract][Full Text] [Related]
33. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?
Cimmino G; D'Amico C; Vaccaro V; D'Anna M; Golino P
Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):517-23. PubMed ID: 21517734
[TBL] [Abstract][Full Text] [Related]
34. Targeting tissue factor as an antithrombotic strategy.
Golino P; Cimmino G
Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
[TBL] [Abstract][Full Text] [Related]
35. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X.
Thiruvikraman SV; Guha A; Roboz J; Taubman MB; Nemerson Y; Fallon JT
Lab Invest; 1996 Oct; 75(4):451-61. PubMed ID: 8874378
[TBL] [Abstract][Full Text] [Related]
36. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
37. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques.
Reininger AJ; Bernlochner I; Penz SM; Ravanat C; Smethurst P; Farndale RW; Gachet C; Brandl R; Siess W
J Am Coll Cardiol; 2010 Mar; 55(11):1147-58. PubMed ID: 20223370
[TBL] [Abstract][Full Text] [Related]
38. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
39. Role of tissue factor in hemostasis and thrombosis.
Mackman N
Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
[TBL] [Abstract][Full Text] [Related]
40. Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles.
Lima LG; Leal AC; Vargas G; Porto-Carreiro I; Monteiro RQ
Thromb Res; 2013 Oct; 132(4):450-6. PubMed ID: 23993901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
